Inhibition of acetylcholinesterase (AChE) can enhance cholinergic transmission, which is beneficial in conditions like Alzheimer’s disease where cholinergic deficits are prominent. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.